Graph
@graphtx.bsky.social
Improving the lives of patients with immune-mediated diseases. We combine complex primary disease models with advanced ML to bridge the gap between pre-clinical models & clinical applications.
🌐 graphtx.com
✏️ graphtx.substack.com
🌐 graphtx.com
✏️ graphtx.substack.com
Parse Biosciences and Graph are partnering to create the world's most comprehensive immune cell perturbation atlas aimed at revealing immune system dysfunction for curative drug discovery. 🧬 🗺️
➡️ Read more: www.parsebiosciences.com/news/parse-b...
➡️ Read more: www.parsebiosciences.com/news/parse-b...
January 20, 2026 at 2:10 PM
Parse Biosciences and Graph are partnering to create the world's most comprehensive immune cell perturbation atlas aimed at revealing immune system dysfunction for curative drug discovery. 🧬 🗺️
➡️ Read more: www.parsebiosciences.com/news/parse-b...
➡️ Read more: www.parsebiosciences.com/news/parse-b...
Fantastic panel at the Evotec Breakfast Reception in SF! Graph co-founder @gregvladimer.bsky.social shared insights alongside leaders from @isomorphiclabs.bsky.social & @medra-ai.bsky.social about how AI helps to unlock disease mechanisms & supports the development of future bio discoveries. 🚀
January 15, 2026 at 3:01 PM
Fantastic panel at the Evotec Breakfast Reception in SF! Graph co-founder @gregvladimer.bsky.social shared insights alongside leaders from @isomorphiclabs.bsky.social & @medra-ai.bsky.social about how AI helps to unlock disease mechanisms & supports the development of future bio discoveries. 🚀
🏔️ Hey Colorado, we’ll be up in the Rockies from 19 - 22 January 2026 for the Autoimmunity & Autoinflammation symposium! We’re looking forward to showcasing our approach of using advanced imaging & data modeling to find clinically-relevant targets & pathways for immune diseases in our latest poster.
January 13, 2026 at 9:08 AM
🏔️ Hey Colorado, we’ll be up in the Rockies from 19 - 22 January 2026 for the Autoimmunity & Autoinflammation symposium! We’re looking forward to showcasing our approach of using advanced imaging & data modeling to find clinically-relevant targets & pathways for immune diseases in our latest poster.
🌊 ⛵ Hey San Francisco, on 13 January 2026 adjacent to the 44th Annual JPM Healthcare Conference, Graph’s co-founder and CEO Greg Vladimer will be speaking on Evotec's panel “Precision at Scale: AI’s impact on Drug Discovery." Let us know if you are in San Francisco and let’s talk techbio!
December 17, 2025 at 11:52 AM
🌊 ⛵ Hey San Francisco, on 13 January 2026 adjacent to the 44th Annual JPM Healthcare Conference, Graph’s co-founder and CEO Greg Vladimer will be speaking on Evotec's panel “Precision at Scale: AI’s impact on Drug Discovery." Let us know if you are in San Francisco and let’s talk techbio!
Just last week, we had a group retreat (aka Graph Con) to a mountain hut in the Alps 🇦🇹. We spent some time honing our cooking skills, enjoying the wintry landscape, and forging our 2026 strategy around immune dysfunction mapping.
We’re already energized for 2026, and we’re just getting started. 💫
We’re already energized for 2026, and we’re just getting started. 💫
December 10, 2025 at 1:35 PM
Just last week, we had a group retreat (aka Graph Con) to a mountain hut in the Alps 🇦🇹. We spent some time honing our cooking skills, enjoying the wintry landscape, and forging our 2026 strategy around immune dysfunction mapping.
We’re already energized for 2026, and we’re just getting started. 💫
We’re already energized for 2026, and we’re just getting started. 💫
Thank you to everyone who attended our AI x Bio meetup last week in Berlin! We had a great time catching up with old friends and making new connections. 🪩 🕺
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
November 26, 2025 at 1:48 PM
Thank you to everyone who attended our AI x Bio meetup last week in Berlin! We had a great time catching up with old friends and making new connections. 🪩 🕺
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
What does it takes to build real prediction power for precision immunology? Hint: it's about mapping immune dysfunction and scaling what's relevant.
➡️ Have a look at what we're building at Graph: graphtx.substack.com/p/building-t...
➡️ Have a look at what we're building at Graph: graphtx.substack.com/p/building-t...
Building the Data Foundation to Scale Precision Immunology
Towards context-conditioned foundation models of immune dysfunction
graphtx.substack.com
November 24, 2025 at 1:10 PM
What does it takes to build real prediction power for precision immunology? Hint: it's about mapping immune dysfunction and scaling what's relevant.
➡️ Have a look at what we're building at Graph: graphtx.substack.com/p/building-t...
➡️ Have a look at what we're building at Graph: graphtx.substack.com/p/building-t...
Immune-mediated diseases are highly complex and heterogeneous, which makes the discovery of precision medicines difficult. In Graph’s most recent poster at #CytoData2025, our research team showcased our systematic approach to address this challenge. 🎯
November 21, 2025 at 10:47 AM
Immune-mediated diseases are highly complex and heterogeneous, which makes the discovery of precision medicines difficult. In Graph’s most recent poster at #CytoData2025, our research team showcased our systematic approach to address this challenge. 🎯
Hey Berlin, we’ll be in town from 20 - 21 November for CytoData 2025! If you want to know more about how we are decoding the functional and molecular niche of immune-mediated diseases for iterative target discovery, come by our poster session to learn more!
November 10, 2025 at 10:26 AM
Hey Berlin, we’ll be in town from 20 - 21 November for CytoData 2025! If you want to know more about how we are decoding the functional and molecular niche of immune-mediated diseases for iterative target discovery, come by our poster session to learn more!
Meet the team behind Graph and say hello to @izepb.bsky.social, Principal Scientist! 🧬⛰️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
October 28, 2025 at 8:02 AM
Meet the team behind Graph and say hello to @izepb.bsky.social, Principal Scientist! 🧬⛰️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
You’re invited to join us for an evening to connect with others building at the intersection of biology, technology, and AI:
📅 19 November 2025, 18:30
📍 Merantix AI Campus, Berlin
👉 Sign up: lu.ma/u4i3i1i3
We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️
📅 19 November 2025, 18:30
📍 Merantix AI Campus, Berlin
👉 Sign up: lu.ma/u4i3i1i3
We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️
Berlin AI x Bio Meetup · Luma
Graph Therapeutics, Merantix Capital, and TechBio Transformers (TBT) are bringing together techbio enthusiasts and experts in Berlin for a meetup, timed…
lu.ma
October 14, 2025 at 1:26 PM
You’re invited to join us for an evening to connect with others building at the intersection of biology, technology, and AI:
📅 19 November 2025, 18:30
📍 Merantix AI Campus, Berlin
👉 Sign up: lu.ma/u4i3i1i3
We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️
📅 19 November 2025, 18:30
📍 Merantix AI Campus, Berlin
👉 Sign up: lu.ma/u4i3i1i3
We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️
✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!
October 7, 2025 at 9:05 PM
✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!
Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.
October 2, 2025 at 10:00 AM
Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.
Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
September 30, 2025 at 8:04 AM
Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬
September 22, 2025 at 6:59 AM
Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬
How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️
September 10, 2025 at 2:02 PM
How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️
Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕
September 8, 2025 at 9:27 AM
Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕
Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
August 27, 2025 at 2:33 PM
Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
August 4, 2025 at 1:20 PM
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿
Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
July 29, 2025 at 9:52 AM
With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿
Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data.
➡️ Check it out: graphtx.substack.com/p/precision-...
➡️ Check it out: graphtx.substack.com/p/precision-...
Precision immunology requires precision data
After a decade iterating on AI drug discovery platforms from Allcyte/Exscientia to Graph, precision medicine demands active investment in data, biological context, and repeated experimental validation
graphtx.substack.com
July 25, 2025 at 12:16 PM
After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data.
➡️ Check it out: graphtx.substack.com/p/precision-...
➡️ Check it out: graphtx.substack.com/p/precision-...
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
July 18, 2025 at 2:11 PM
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
June 30, 2025 at 11:52 AM
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
We're hiring! 📢
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Graph Therapeutics hiring Quantitative Systems Biologist (m/f/d) in Klosterneuburg, Lower Austria, Austria | LinkedIn
Posted 4:35:54 PM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.
www.linkedin.com
June 14, 2025 at 7:45 AM
We're hiring! 📢
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍
Want to know more? Reach out to us and apply via the link below! ⬇️
www.linkedin.com/jobs/view/42...
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
May 26, 2025 at 1:10 PM
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️